Metabolic Brain Disease

, Volume 28, Issue 4, pp 619–627 | Cite as

Insulin resistance possible risk factor for cognitive impairment in fibromialgic patients

  • Antonietta Fava
  • Massimiliano Plastino
  • Dario Cristiano
  • Antonio Spanò
  • Stefano Cristofaro
  • Carlo Opipari
  • Antonio Chillà
  • Fatima Casalinuovo
  • Carmen Colica
  • Matteo De Bartolo
  • Domenico Pirritano
  • Domenico Bosco
Original Paper

Abstract

To evaluate glucose metabolism and/or insulin resistance (IR) in 96 patients with Fibromyalgia (FM), associated or not to cognitive impairment. We investigated glucose metabolism in 96 FM patients. Enrolled patients were divided into two groups: 48 patients with memory deficit (group A) and 48 without memory deficit (control group). We evaluated glucose and insulin levels after a 2 h-Oral-Glucose-Tolerance-Test (2 h-OGTT) and insulin resistance (IR) by the homeostasis model assessment formula (HOMA). Body Mass Index (BMI), waist-to-hip-ratio (WHR), anxiety level, fasting plasma insulin and Non-Steroidal Anti-Inflammatory agents use were higher in patients with FM with memory impairment; while age, sex, waist circumference, education level, fasting plasma glucose, glycate hemoglobin, triglycerides, blood lipid profile, C- Reactivity-Protein (CRP), blood pressure and smoking habits were similar in both groups. Following OGTT the prevalence of glucose metabolism abnormalities was significantly higher in group A. IR was present in 79 % patients, of whom 23 % had also impaired glucose tolerance, 4 % newly diagnosed diabetes mellitus and 52 % IR only. Obesity and overweight prevailed in group A. IR, but not BMI or WHR was associated to an increased risk of memory impairment (OR = 2,6; 95 % CI: 1,22–3,7). The results of this study suggest that IR may represent a risk factor for memory impairment in fibromialgic patients.

Keywords

Cognitive deficits Dementia Diabetes mellitus Pain syndrome Insulin resistance 

Abbreviations

NGM

Normal Glucose Metabolism

IGT

Impaired Glucose Tolerance

NDDM

Newly Diagnosed Diabetes Mellitus

IR

Insulin Resistance

References

  1. American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, International Diabetes Federation (2007) Consensus statement on the world wide standardization on the HbA1c measurement. Diabetologia 50:2042–2043CrossRefGoogle Scholar
  2. Beck AT, Ward C, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571PubMedCrossRefGoogle Scholar
  3. Bingham EM, Hopkins D, Smith D, Pernet A, Hallett W, Reed L, Marsden PK, Amiel SA (2002) The role of insulin in human brain glucose metabolism: an 18-fluoro-deoxyglucose positron emission tomography study. Diabetes 51:3384–3390PubMedCrossRefGoogle Scholar
  4. Blanchard JG, Duncan PM (1997) Effect of combinations of insulin, glucose and scopolamine on radial arm maze performance. Pharmacol Biochem Behav 58(1):209–214Google Scholar
  5. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, Alberiche M, Bonadonna RC, Muggeo M (1998) Prevalence of insulin resistance in metabolic disorders: the Bruneck study. Diabetes 47:1643–1649PubMedCrossRefGoogle Scholar
  6. Bosco D, Costa R, Plastino M, Branca D, Cotronei P, Santacroce N, Siniscalchi A, Consoli D, Ceccotti C, Mungari P, Fava A (2009) Glucose metabolism in the idiopathic blepharoptosis: utility of the oral glucose tolerance test (OGTT) and of the insulin resistance index. J Neurol Sci 284:24–28PubMedCrossRefGoogle Scholar
  7. Bosco D, Fava A, Plastino M, Montalcini T, Pujia A (2011) Possible implications of insulin resistance and glucose metabolism in Alzheimer’s disease pathogenesis. J Cell Mol Med 15(9):1807–1821PubMedCrossRefGoogle Scholar
  8. Cleeman JI (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). J Am Med Assoc 285(19):2486–2497CrossRefGoogle Scholar
  9. Cohen S, Kamarck T, Mermelstein R (1983) A global measure of perceived stress. J Health Soc Behav 24:385–396PubMedCrossRefGoogle Scholar
  10. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Report of the expert committee on the diagnosis and classification of Diabetes Mellitus. Diabetes Care 26:S4–S20CrossRefGoogle Scholar
  11. Folstein MF, Folstein SE, Mc Hugh PR (1975) Mini mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMedCrossRefGoogle Scholar
  12. Grace GM, Nielson WR, Hopkins M, Berg MA (1999) Concentration and memory deficits in patients with fibromyalgia syndrome. J Clin Exp Neuropsychol 21:477–487PubMedCrossRefGoogle Scholar
  13. Greisen J, Juhl CB, Grofte T, Vilstrup H, Jensen TS, Schmitz O (2001) Acute pain induces insulin resistance in humans. Anesthesiology 95:578–584PubMedCrossRefGoogle Scholar
  14. Jonides J (1995) Working memory and thinking. In: Smith EE, Osherson DN (eds) An invitation to cognitive science: thinking, vol 3. MIT Press, Cambridge, pp 215–265Google Scholar
  15. Landro NI, Stiles TC, Sletvold H (1997) Memory functioning in patients with primary fibromyalgia and major depression and healthy controls. J Psychosom Res 42:297–306PubMedCrossRefGoogle Scholar
  16. Landsberg L (1999) Role of the sympathetic adrenal system in the pathogenesis of the insulin resistance syndrome. Ann NY Acad Sci 892:84–90PubMedCrossRefGoogle Scholar
  17. Laws A, Reaven GM (1993) Insulin resistance and risk factors for coronary heart disease. Bailliere’s Clin Endocrinol Metabol 7:1063–1078CrossRefGoogle Scholar
  18. Leavitt F, Katz RS (2006) Distraction as a key determinant of impaired memory in patients with fibromyalgia. J Rheumatol 33:127–132PubMedGoogle Scholar
  19. Lee ZS, Critchley JA, Tomlinnson B, Young RP, Thomas GN, Cockram CS, Chan TY, Chan JC (2001) Urinary epinephrine and norepinephrine 3interrelations with obesity, insulin, and the metabolic syndrome in Hong Kong Chinese. Metabolism 50:135–143PubMedCrossRefGoogle Scholar
  20. Lezak MD (1995) Neuropsychological assessment. Oxford University Press, New York, pp 333–335Google Scholar
  21. Lipman RS (1982) Differentiating anxiety and depression in anxiety disorders: use of rating scale. Psychormacol Bull 18:69–77Google Scholar
  22. Loevinger BL, Muller D, Alonso C, Coe CL (2007) Metabolic syndrome in women with chronic pain. Metabolism 56:87–93PubMedCrossRefGoogle Scholar
  23. Luchsinger JA, Tang MX, Shea S, Mayeux R (2004) Hyperinsulinemia and risk of Alzheimer’s disease. Neurology 63:1187–1192PubMedCrossRefGoogle Scholar
  24. Martinez-Lavin M, Hermosillo AG (2000) Autonomic nervous system dysfunction may explain the multisystem features of fibromyalgia. Semin Arthritis Rheum 29:197–199PubMedCrossRefGoogle Scholar
  25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRefGoogle Scholar
  26. Meenan RF, Mason JH, Anderson J, Guccione AA, Kazis LE (1992) AIMS2: the content and properties of a revised and expanded arthritis impact measurement scale health status questionnaire. Arthritis Rheum 35:1–10PubMedCrossRefGoogle Scholar
  27. Melzack R (1987) The short-form McGill pain questionnaire. Pain 30:191–197PubMedCrossRefGoogle Scholar
  28. Mersekey H, Bog-Duk N (1994) Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. Monograph fort he task force of taxonomy, 2nd edn. International Association for the Study of Pain, Seattle, pp 45–47Google Scholar
  29. Okifuji A, Bradshaw DH, Olson C (2009) Evaluating obesity in fibromyalgia: neuroendocrine biomarkers, symptoms, and functions. Clin Reumatol 28:475–478CrossRefGoogle Scholar
  30. Ott A, Stolk RP, Van Harskamp F, Pols HA, Hofman A, Breteler MM (1999) Diabetes mellitus and the risk of dementia: the Rotterdarm Study. Neurology 53:1937–1942PubMedCrossRefGoogle Scholar
  31. Park DC, Smith AD, Lautenschlager G, Earles JL, Frieske D, Zwahr M, Gaines CL (1996) Mediators of long-term memory performance across the life span. Psychol Aging 22:137–142Google Scholar
  32. Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM (1998) The revised piper fatigue scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 25:677–684PubMedGoogle Scholar
  33. Pi-Sunyer FX (2000) Obesity: criteria and classification. Proc Nutr Soc 59:505–509PubMedCrossRefGoogle Scholar
  34. Plastino M, Fava A, Pirritano D, Cotronei P, Sacco N, Sperlì T, Spanò A, Gallo D, Mungari P, Consoli D, Bosco D (2010) Effects of insulin therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2. J Neurol Sci 288:112–116PubMedCrossRefGoogle Scholar
  35. Suhr JA (2003) Neuropsychological impairment in fibromyalgia: relation to depression, fatigue and pain. J Psychosom Res 55:321–329PubMedCrossRefGoogle Scholar
  36. Svetvold H, Stiles TC, Landro NI (1995) Information processing in primary fibromyalgia, major depression and healthy controls. J Rheumatol 22:137–142Google Scholar
  37. Talbot K, Wang H-Y, Kazi H, Han LY, Bakshi KP, Stucky A, Fuino RL, Kawaguchi KR, Samoyedny AJ, Wilson RS, Arvanitakis Z, Schneider JA, Wolf BA, Bennett DA, Trojanowski JQ, Arnold SE (2012) Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation and cognitive decline. J Clin Investig 122:1316–1338PubMedCrossRefGoogle Scholar
  38. Tewes U (1991) Handbuch and Testanweisungen fur den Hamburg-Wechsler Intelligenztest fur Erwachesene RevisionGoogle Scholar
  39. Tsigos C, Chrousos GP (2004) Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 57:451–458CrossRefGoogle Scholar
  40. Uchida I, Asoh T, Shirasaka C, Tsuji H (1988) Effect of epidural analgesia on postoperative insulin resistance as evaluated by insulin clamp technique. Br J Surg 75:557–562PubMedCrossRefGoogle Scholar
  41. Wallitt B, Roebuck-Spencer T, Bleiberg J, Forster G, Weinstein A (2008) Automated neuropsychiatric measurements of information processing in fibromyalgia. Reumathol Int 28:561–566CrossRefGoogle Scholar
  42. Watson GS, Bernhardt T, Reger MA, Chorleton BA, Baker LD, Peskind ER, Asthana S, Plymate SR, Frolich L, Craft S (2006) Insulin effects on CSF norepinephrine and cognition in Alzheimer disease. Neurobiol Aging 27:38–41PubMedCrossRefGoogle Scholar
  43. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P (1990) The American College of Rheumatology criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–172PubMedCrossRefGoogle Scholar
  44. Wolfe F, Ross K, Anderson J, Russell IJ (1995) Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms. J Rheumatol 22:151–156PubMedGoogle Scholar
  45. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB (2010) The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 62:600–610CrossRefGoogle Scholar
  46. Xu WL, Qiu CX, Wahlin A, Winblad B, Fratiglioni L (2004) Diabetes mellitus and risk of dementia in the Kungshol men project: a 6-year follow-up study. Neurology 63:1181–1186PubMedCrossRefGoogle Scholar
  47. Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, Tylavsky FA, Newman AB (2004) The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 292:2237–2242PubMedCrossRefGoogle Scholar
  48. Yanmaz MN, Mert M, Korkmaz M (2011) The prevalence of fibromyalgia syndrome in a group of patients with diabetes mellitus. Rheumatol Int 8:1018–1022Google Scholar
  49. Yesavage JA, Brink TL (1983) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17:37–49CrossRefGoogle Scholar
  50. Yunus MB, Dailey JW, Aldag JC, Masi AT, Jobe PC (1992) Plasma and urinary catecholamines in primary fibromyalgia: a controlled study. J Rheumatol 19:95–97PubMedGoogle Scholar
  51. Ziemus B, Baumann O, Luerding R, Schlosser R, Schuierer G, Bogdahn U, Greenlee MW (2007) Impaired working-memory after cerebellar infarcts paralleled by changes in BOLD signal of a cortico-cerebellar circuit. Neuropsychologia 45:2016–2024PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Antonietta Fava
    • 1
  • Massimiliano Plastino
    • 2
  • Dario Cristiano
    • 2
  • Antonio Spanò
    • 2
  • Stefano Cristofaro
    • 2
  • Carlo Opipari
    • 2
  • Antonio Chillà
    • 3
  • Fatima Casalinuovo
    • 2
  • Carmen Colica
    • 4
  • Matteo De Bartolo
    • 5
  • Domenico Pirritano
    • 2
  • Domenico Bosco
    • 2
  1. 1.EndocrinologyFondazione UALSICatanzaroItaly
  2. 2.Department of Neuroscience“S. Giovanni di Dio” HospitalCrotoneItaly
  3. 3.Department of Psychiatry“S. Giovanni di Dio” HospitalCrotoneItaly
  4. 4.National Research CouncilCatanzaroItaly
  5. 5.Neurophysiology UnitHospital - RossanoRossanoItaly

Personalised recommendations